Australian headquartered crop protection company Nufarm has reported a strong set of first-half FY2026 results, but it was Europe that stood out, delivering 17% EBITDA growth in local currency despite ongoing regulatory and market pressures.
The result highlights a notable divergence in regional performance and challenges the typical narrative that Europe’s tighter regulatory environment is necessarily a drag on profitability.
“Europe was the standout contributor,” said CEO Rico Christensen, pointing to improved product mix and lower operating costs following the implementation of a performance improvement programme.
The region’s performance comes as Nufarm sharpens its strategic focus on higher-margin products and disciplined cost control, rather than pursuing volume growth.
Margin over volume drives earnings uplift
Group-wide, Nufarm delivered EBITDA up 18% year-on-year to AUD 243m, net profit up 35% to AUD 52m and free cash flow improvement of AUD 193m.
However, revenue declined year-on-year – a deliberate move as the company prioritised earnings quality over top-line growth.
“Revenue was lower… reflecting a deliberate focus on improving mix and prioritizing margin over volume,” Christensen said.
That strategy translated into a record gross margin of 33.1%, the highest level reported by the company in two decades.
Europe’s performance reflects strategic reset
The strong European result appears to be a direct outcome of Nufarm’s wider strategy refresh, which is centred on narrowing portfolio focus, rationalising lower-margin assets and reducing cost and operational complexity.
In Europe specifically, savings generated from performance improvement initiatives have already begun flowing through to the bottom line.
“We saw really good progress in improving our margins and returns this first half, and now we are focused on maintaining that momentum,” Christensen said.
Nufarm’s performance stands in contrast to a broader industry picture, where companies continue to flag long approval timelines, regulatory complexity and tightening pesticide rules as major constraints on growth in Europe.
Regional divergence underscores shifting market dynamics
While Europe delivered standout growth, other regions showed more mixed performance. In North America EBITDA was up 11%, supported by stronger performance in turf, ornamental, and Canada. In APAC, EBITDA was down 15% due to dry weather in Australia and currency headwinds.
The divergence underscores how regional execution and portfolio strategy are becoming more critical than macro conditions alone in determining performance.
Notably, Nufarm attributed margin improvements primarily to portfolio rationalisation and product mix, rather than external factors such as pricing or inventory dynamics.
Crop protection and seeds both contribute
In crop protection, EBITDA rose 6% in constant currency, driven by regional strength, improved margins and cost discipline. Meanwhile, the Seed Technologies division delivered EBITDA up 8%, strong performance in Hybrid Seeds and improved results in Emerging Platforms.
The company also extended its carinata biofuel crop offtake agreement with BP to 2050, signalling continued investment in alternative crop value chains.
Strategy shift signals broader industry trend
Nufarm’s performance reflects a broader shift across the crop protection industry, where companies are moving away from volume-led growth towards margin optimisation and capital discipline.
“We are choosing a different direction,” Christensen said. “Not only choosing what we will do, but also what we will not do.”
A test case for Europe’s agchem narrative?
For agribusiness leaders, Nufarm’s results offer an important signal.
While Europe remains one of the most regulated crop protection markets globally, the company’s performance suggests that profitability is still achievable through portfolio discipline, cost control, and targeted market positioning.
In an environment where many players continue to grapple with pricing pressure and volume volatility, Europe’s 17% EBITDA growth stands out as a reminder that strategy – not just regulation – will determine success.
